Barbara Castella
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
Journal: Molecular oncology
Published: July 27, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 03, 2023
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status.
Journal: Frontiers in immunology
Published: October 18, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Journal: Haematologica
Published: September 06, 2021
Molecular dynamics of targeting CD38 in multiple myeloma.
Journal: British journal of haematology
Published: September 20, 2020
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: July 21, 2020
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma.
Journal: Frontiers in bioscience (Landmark edition)
Published: October 06, 2019
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
Journal: Seminars in cell & developmental biology
Published: March 28, 2019
CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: March 01, 2019
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 03, 2018
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.
Journal: Frontiers in oncology
Published: August 02, 2018
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression.
Journal: Frontiers in immunology
Published: April 08, 2018
Last Updated: 09/26/2026